CanniMed’s Board of Directors recommends shareholders vote their GREEN proxy to approve the Newstrike Acquisition, which will lead to significant value creation for all CanniMed shareholders.

The Board also unanimously concluded that Aurora Cannabis Inc.’s Hostile Bid significantly undervalues the CanniMed shares and is not in the best interests of the Company or its shareholders.

The Board urges shareholders to reject the Hostile Bid by taking no action. Shareholders are advised not to not tender their CanniMed shares.

Now is NOT the time to tender to Aurora’s Hostile Bid because CanniMed is poised to capitalize on this market opportunity in a real way with the Newstrike Acquisition.

By refusing to tender, shareholders will send an important message: They will not allow Aurora to block them from maximizing the value of their investment in CanniMed.

The cut-off for voting your shares on the GREEN proxy is January 19th at 10:00 a.m. (Toronto time)

VOTE YOUR GREEN PROXY TO ACQUIRE NEWSTRIKE. DO NOT TENDER YOUR SHARES TO AURORA.